TELO Stock Analysis: Buy, Sell, or Hold?
TELO - Telomir Pharmaceuticals, Inc. Common Stock
$1.25
0.00 (0.00%)
▲
5d:
-2.34%
30d:
-3.1%
90d:
-2.34%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When TELO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TELO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: TELO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: TELO is currently trading at $1.25, which is considered fair relative to its 30-day fair value range of $1.22 to $1.31.
Technical Outlook: Technically, TELO is in a downtrend. Immediate support is located at $1.20, while resistance sits at $1.31.
Market Sentiment: TELO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.50 (+1140.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TELO is in a downtrend. Immediate support is located at $1.20, while resistance sits at $1.31.
Market Sentiment: TELO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.50 (+1140.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.22 -
$1.31
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1140.0% below Wall St target ($15.50)
Trading Range Analysis
30-Day Trading Range
$1.22 -
$1.31
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.20
Resistance Level
$1.31
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.46
Wall Street Target
$15.50
(+1140.0%)
Share & Embed Analysis
Last updated: June 24, 2026 11:44 AM ET
Data refreshes hourly during market hours. Next update: 12:44 PM
Data refreshes hourly during market hours. Next update: 12:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
